共 50 条
- [32] Safety and efficacy of quinidine sulfate in slow-channel congenital myasthenic syndrome MYASTHENIA GRAVIS AND RELATED DISEASES: DISORDERS OF THE NEUROMUSCULAR JUNCTION, 1998, 841 : 203 - 205
- [33] A retrospective clinical study of the treatment of slow-channel congenital myasthenic syndrome Journal of Neurology, 2012, 259 : 474 - 481
- [35] Slow-channel myasthenic syndrome caused by enhanced activation, desensitization, and agonist binding affinity attributable to mutation in the M2 domain of the acetylcholine receptor alpha subunit JOURNAL OF NEUROSCIENCE, 1997, 17 (15): : 5651 - 5665
- [40] Acetylcholine Receptor Gating in a Zebrafish Model for Slow-Channel Syndrome JOURNAL OF NEUROSCIENCE, 2012, 32 (23): : 7941 - 7948